Download
s00508-020-01750-6.pdf 417,22KB
WeightNameValue
1000 Titel
  • Considering additive effects of polypharmacy
1000 Autor/in
  1. Lexow, Monika |
  2. Wernecke, Kathrin |
  3. Schmid, Gordian L. |
  4. Sultzer, Ralf |
  5. Bertsche, Thilo |
  6. Schiek, Susanne |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-22
1000 Erschienen in
1000 Quellenangabe
  • 133(15-16):816-824
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00508-020-01750-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373749/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Potential additive effects of polypharmacy are rarely considered in adverse events of geriatric patients living in long-term care facilities. Our aim, therefore, was to identify adverse events in this setting and to assess plausible concomitant drug causes.!##!Methods!#!A cross-sectional observational study was performed in three facilities as follows: (i) adverse event identification: we structurally identified adverse events using nurses' interviews and chart review. (ii) Analysis of the concomitantly administered drugs per patient was performed in two ways: (ii.a) a review of summary of product characteristics for listed adverse drug reactions to identify possible causing drugs and (ii.b) a causality assessment according to Naranjo algorithm.!##!Results!#!(i) We found 424 adverse events with a median of 4 per patient (range 1-14) in 103 of the 104 enrolled patients (99%). (ii.a) We identified a median of 3 drugs (range 0-11) with actually occurring adverse events listed as an adverse drug reaction in the summary of product characteristics. (ii.b) Causality was classified in 198 (46.9%) of adverse events as 'doubtful,' in 218 (51.2%) as 'possible,' in 7 (1.7%) as 'probable,' and in 1 (0.2%) adverse event as a 'definitive' cause of the administered drugs. In 340 (80.2%) of all identified adverse events several drugs simultaneously reached the highest respective Naranjo score.!##!Conclusion!#!Patients in long-term facilities frequently suffer from many adverse events. Concomitantly administered drugs have to be frequently considered as plausible causes for adverse events. These additive effects of drugs should be more focused in patient care and research.
1000 Sacherschließung
lokal Aged [MeSH]
lokal Humans [MeSH]
lokal Long-Term Care [MeSH]
lokal Cross-Sectional Studies [MeSH]
lokal Naranjo algorithm
lokal Drug-Related Side Effects and Adverse Reactions/epidemiology [MeSH]
lokal Original Article
lokal Adverse drug reactions
lokal Causality [MeSH]
lokal Nursing homes
lokal Observational Studies as Topic [MeSH]
lokal Polypharmacy [MeSH]
lokal Aged
lokal Side effects
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TGV4b3csIE1vbmlrYQ==|https://orcid.org/0000-0002-2944-7282|https://frl.publisso.de/adhoc/uri/U2NobWlkLCBHb3JkaWFuIEwu|https://frl.publisso.de/adhoc/uri/U3VsdHplciwgUmFsZg==|https://orcid.org/0000-0002-4930-6655|https://orcid.org/0000-0001-8194-7180
1000 Hinweis
  • DeepGreen-ID: 1b3ba2c747014db181172799ebc3a2af ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
  1. Considering additive effects of polypharmacy
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6467802.rdf
1000 Erstellt am 2023-11-17T12:23:53.293+0100
1000 Erstellt von 322
1000 beschreibt frl:6467802
1000 Zuletzt bearbeitet Fri Dec 01 06:50:20 CET 2023
1000 Objekt bearb. Fri Dec 01 06:50:20 CET 2023
1000 Vgl. frl:6467802
1000 Oai Id
  1. oai:frl.publisso.de:frl:6467802 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source